• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Diflucan Online Visit Our Pharmacy ↓

Click HERE To Buy Diflucan Online ↓




  • Addressing Common Myths about Diflucan Usage

    Debunking the Myth: Diflucan Is Just an Antibiotic


    Diflucan, often misunderstood as merely an antibiotic, is actually an antifungal medication with specific purposes. Unlike antibiotics, which target bacteria, Diflucan is designed to combat fungal infections, particularly those caused by yeast. This distinction is crucial because using the wrong type of medication can be ineffective and may contribute to resistance.

    One of the most common applications of Diflucan is in the treatment of yeast infections, a prevalent condition affecting many individuals. By inhibiting the growth of fungi, Diflucan effectively alleviates symptoms such as itching and discomfort. It is important to recognize its unique role in managing fungal infections, rather than lumping it with general antibiotics.

    Understanding Diflucan's true nature involves recognizing its purpose beyond bacterial infections. This is vital for proper healthcare guidance and effective treatment plans.

    Characteristic Antibiotic Diflucan (Antifungal)
    Targets Bacteria Fungi
    Common Use Bacterial Infections Yeast Infections
    Resistance Concern Yes Yes



    Understanding the Reality: Diflucan and Yeast Infections



    Diflucan, generically known as fluconazole, is a groundbreaking antifungal medication distinct from traditional antibiotics. While antibiotics target bacteria, Diflucan specifically combats fungal infections, particularly those caused by yeast. This distinction is crucial, as taking an antibiotic won't resolve a yeast infection and can sometimes worsen it by disrupting natural flora balances. Diflucan works by inhibiting the growth of yeast, effectively addressing conditions like vaginal yeast infections, thrush, and others without the collateral damage associated with antibacterial treatments.

    Despite its efficacy, Diflucan isn't a cure-all. Yeast infections can vary in severity and response to treatment; a single dose isn't always sufficient. Understanding that Diflucan requires time to disrupt fungal cell membranes helps manage expectations. Depending on the infection's nature and persistence, some patients may need additional doses. Recognizing Diflucan's specific role better equips individuals to seek appropriate treatment and appreciate its unique therapeutic value.



    Setting the Record Straight: Diflucan’s Side Effects


    When considering treatments for yeast infections, Diflucan often comes to the forefront. However, along with its benefits, some users are wary of potential side effects. It’s essential to understand that while Diflucan can induce effects like headaches, dizziness, or stomach upset, these occurrences are relatively rare and typically mild. Most individuals tolerate the medication well, but awareness and consultation with a healthcare provider remain crucial.

    Another layer of concern is the risk of more severe side effects, which though uncommon, can include liver issues or severe skin reactions. These are more frequently seen in individuals with pre-existing health conditions. Thus, maintaining open communication with a healthcare provider ensures that any risks are minimized and managed proactively.

    Moreover, it’s important to note how individual health conditions can influence the likelihood of experiencing side effects. Factors such as existing liver problems or allergies can increase susceptibility. By being informed about potential interactions and engaging in clear dialogue with healthcare professionals, patients can better navigate their treatment with Diflucan, ensuring both safety and reliability throughout the process.



    Common Misconception: Diflucan’s Immediate Effectiveness



    Many patients find themselves surprised when Diflucan doesn’t provide swift relief from symptoms. The misconception that this antifungal medication works instantly stems from its single-dose regimen, creating the false impression of immediate results. In reality, Diflucan operates by inhibiting the growth of yeast, gradually reducing symptoms over several days. This process, while effective, requires time as the body naturally eradicates the infection with the aid of the medication.

    Expectations for overnight effectiveness often lead to frustration and unnecessary anxiety. However, understanding that Diflucan's mechanism involves gradual restoration can help manage expectations. Patience is crucial, as the drug’s therapeutic effects depend on individual factors such as the severity of the infection and personal response to treatment. Consulting with a healthcare provider can offer reassurance and guidance tailored to specific needs.



    Clarifying the Dosage: Single Pill Versus Ongoing Treatment


    While many people are familiar with Diflucan's reputation for addressing yeast infections, the nuances of its dosing require a closer look. Often, patients expect a single pill to suffice, yet understanding when multiple doses are necessary is crucial. Typically, a solitary dose of diflucan is prescribed for uncomplicated cases. However, recurrent or severe infections might require an extended treatment plan to achieve full efficacy. This distinction is paramount for ensuring proper management of the condition.

    Dosage Type Use Case
    Single Dose Uncomplicated Yeast Infections
    Ongoing Treatment Recurrent or Severe Infections

    Patients should always consult with healthcare providers to ascertain the appropriate regimen. Variations in treatment can depend on individual health factors, underlying conditions, and the specific strain involved. Hence, while a quick fix is appealing, proper guidance ensures long-term relief, preventing potential complications.



    Exploring Drug Interactions: Diflucan with Other Medications


    Diflucan, known generically as fluconazole, is widely used for treating fungal infections, but it's crucial to be aware of potential interactions with other medications. For instance, when combined with blood thinners like warfarin, Diflucan can amplify blood thinning, increasing the risk of bleeding. Similarly, if taken with certain antidiabetic medications, it can cause blood sugar levels to fluctuate unexpectedly.

    Moreover, Diflucan can interact with drugs affecting heart rhythm, such as some antihistamines, leading to potentially serious heart issues. It's also important to consider its interaction with certain cholesterol-lowering drugs, like statins, potentially enhancing their side effects. Due to these potential interactions, consulting with a healthcare professional before combining Diflucan with other medications is essential. Being informed helps ensure both effectiveness and safety in treatment.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.